Enlivex Therapeutics Ltd
F:1BT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enlivex Therapeutics Ltd
F:1BT
|
IL |
|
K
|
Kureha Corp
F:0K1
|
JP |
|
A
|
Anhui Expressway Co Ltd
F:HU7
|
CN |
|
E
|
Esker SA
F:EKE
|
FR |
|
United Arrows Ltd
OTC:UARWF
|
JP |
|
T
|
Techtronic Industries Co Ltd
XMUN:TIB1
|
HK |
|
F
|
First Pacific Co Ltd
SWB:FPC
|
HK |
|
Jersey Oil and Gas PLC
F:TPC1
|
JE |
|
I
|
Independent Bank Group Inc
F:I3B
|
US |
|
C
|
China Evergrande Group
XMUN:EV1
|
CN |
|
A
|
Aeon Mall Co Ltd
F:9DH
|
JP |
|
Ichiyoshi Securities Co Ltd
F:8KF
|
JP |
|
D
|
Daphne International Holdings Ltd
F:PSX
|
CN |
|
I
|
Internet Initiative Japan Inc
F:IIJ
|
JP |
|
P
|
Paylocity Holding Corp
F:0P7
|
US |
|
Synairgen PLC
F:OMY
|
UK |
Bankruptcy Probability
Enlivex Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Enlivex Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
23.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Enlivex Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Enlivex Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
